For research use only. Not for therapeutic Use.
INH6 (Cat No.:R062470 ) is a small molecule inhibitor developed for targeting specific protein-protein interactions involved in cancer cell survival and proliferation. It primarily functions by disrupting the function of certain key proteins associated with the growth of cancer cells, particularly in aggressive tumor types. Preclinical studies suggest that INH6 may help in reducing tumor progression and metastasis. While the full therapeutic potential is still under exploration, INH6 shows promise as a novel approach for targeted cancer therapy, especially in drug-resistant cancers.
Catalog Number | R062470 |
CAS Number | 1001753-24-7 |
Synonyms | N-[4-(2,4,6-Trimethylphenyl)-2-thiazolyl]benzamide |
Molecular Formula | C19H18N2OS |
Purity | ≥95% |
Target | Apoptosis |
Solubility | Soluble in DMSO > 10 mM |
Storage | Desiccate at -20C |
IUPAC Name | N-[4-(2,4,6-trimethylphenyl)-1,3-thiazol-2-yl]benzamide |
InChI | 1S/C19H18N2OS/c1-12-9-13(2)17(14(3)10-12)16-11-23-19(20-16)21-18(22)15-7-5-4-6-8-15/h4-11H,1-3H3,(H,20,21,22) |
InChIKey | WCZLNJTXHZPHLM-UHFFFAOYSA-N |
SMILES | CC1=CC(=C(C(=C1)C)C2=CSC(=N2)NC(=O)C3=CC=CC=C3)C |